Predicting Unilateral Prostate Cancer Based On Biopsy Features: Implications For Focal Ablative Therapy Results From The SEARCH Database

October 29, 2007 – 1:09 pm | posted in Prostate

UroToday.com- New focal ablative therapies that just treat areas of the prostate containing tumor are being reported. However, according to a report in the October, 2007 issue of the Journal of Urology from the SEARCH Database, unilateral prostate cancer (CaP) can not be identified preoperatively by biopsy criteria.

The SEARCH database is comprised of a multicenter Veterans Affairs dataset of patients with CaP. The authors identified 261 men with clinical stage T1c or T2 CaP, PSA

Popularity: 2% [?]

Also Read

  • Perineural Invasion Associated With Increased Cancer-Specific Mortality After External Beam Radiation Therapy For Men With Low And Intermediate-Risk
  • Residual And Recurrent Disease Following Renal Energy Ablative Therapy: A Multi-Institutional Study
  • EAU Session On Prostate Biopsy 1
  • New Classification Better Identifies Prostate Cancer Patients To Benefit From Hormone Therapy
  • New Patient Database Enables Presentation Of Safety, Efficacy Data For Cryoablation
  • What Is The Best Approach For Screen-Detected Low Volume Cancers?
  • Prevalence Of Prostate Cancer Among Hypogonadal Men With Prostate-Specific Antigen Levels Of 4.0 Ng/mL Or Less
  • Metastatic Disease Of Screen-Detected Prostate Cancer
  • Prostate cancer killed 140 N.H. men in 2006
  • MIME Robotic Device For Upper-limb Neurorehabilitation In Subacute Stroke Subjects: A Follow-up Study
  • You must be logged in to post a comment.